Clinical Trial Update: A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment [NA]

View source ↗

Summary

This clinical trial evaluates a virtually delivered diet intervention (LASO-3) intended to improve chemotherapy-induced peripheral neuropathy in cancer survivor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Hematologic Malignancies
• Solid Tumors

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphatic System Neoplasm | NA | Status: RECRUITING